NASDAQ: COYA
Coya Therapeutics Inc Stock Ownership - Who owns Coya Therapeutics?

Insider buying vs selling

Have Coya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David S. SnyderChief Financial Officer2024-11-141,800$7.19
$12.93kBuy
Arun SwaminathanChief Executive Officer2024-11-135,000$7.36
$36.80kBuy
Fred GrossmanChief Medical Officer2024-11-112,710$7.37
$19.97kBuy
Arun SwaminathanChief Executive Officer2024-11-115,000$7.34
$36.69kBuy

1 of 1

COYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when COYA insiders and whales buy or sell their stock.

COYA Shareholders

What type of owners hold Coya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Dme Capital Management LP9.84%1,646,440$10.16MInstitution
Aigh Capital Management LLC7.18%1,201,152$7.41MInstitution
Howard Berman5.68%949,338$5.86MInsider
Bertex LLC5.62%939,338$5.80MInsider
Vanguard Group Inc5.03%840,471$5.19MInstitution
Wilbur L. Ross Jr.0.99%165,016$1.02MInsider
CM Management LLC0.96%160,000$987.20kInstitution
Geode Capital Management LLC0.90%150,576$929.05kInstitution
Blackrock Inc0.46%76,193$470.11kInstitution
Newbridge Financial Services Group Inc0.42%70,000$431.90kInstitution

1 of 3

COYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
COYA26.57%12.80%Net Buying
ATOS23.17%14.77%Net BuyingNet Buying
ENTX16.54%16.12%Net BuyingNet Buying
GNLX14.08%6.43%Net Selling
MGNX70.26%29.74%Net SellingNet Selling

Coya Therapeutics Stock Ownership FAQ

Who owns Coya Therapeutics?

Coya Therapeutics (NASDAQ: COYA) is owned by 26.57% institutional shareholders, 12.80% Coya Therapeutics insiders, and 60.63% retail investors. Howard Berman is the largest individual Coya Therapeutics shareholder, owning 949,338.00 shares representing 5.68% of the company. Howard Berman's Coya Therapeutics shares are currently valued at $5.79M.

If you're new to stock investing, here's how to buy Coya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.